ARKK is trading 3.1% down today as the Nasdaq Composite declines and risk appetite weakens across the broader market.
- Rising geopolitical tensions and surging oil prices are driving an investor rotation out of high-beta, AI-linked, and semiconductor stocks.
- The selloff is heavily impacting innovation-focused funds due to their high exposure to healthcare and technology growth names.
- ARKK typically underperforms when markets enter a de-risking phase and move away from speculative innovation assets.